Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: Formulation, characterization and in vivo evaluation

Journal of Microencapsulation

Volumn 27, Issue 6, 2010, Pages 471-478

  Sun, Shaoping ^a,b,c   Liang, Na ^a   Piao, Hongze ^a   Yamamoto, Hiromitsu ^c   Kawashima, Yoshiaki ^c   Cui, Fude ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b HEILONGJIANG UNIVERSITY   (China)

^c AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Bioavailability; Insulin complex; Nanoparticles; PLGA; Sodium oleate

Indexed keywords

INSULIN; NANOPARTICLE; OLEATE SODIUM; PIG INSULIN; POLYGLACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DIFFUSION; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULARY; DRUG SYNTHESIS; EMULSION; ENCAPSULATION; IN VIVO STUDY; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; RAT; STREPTOZOCIN DIABETES; TREATMENT RESPONSE;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; INSULIN; LACTIC ACID; MALE; NANOPARTICLES; OLEIC ACID; POLYGLYCOLIC ACID; RATS; RATS, WISTAR;

EID: 77955451745     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652040903515490     Document Type: Article

References (24)

1. Adjei A, Rao S, Garren J, Menon G, Vadnere M. 1993. Effect of ion-pairing on 1-octanol-water partitioning of peptide drugs. I: The nonapeptide leuprolide acetate. Int J Pharm 90:141-149.
2. Carino G, Mathiowitz E. 1999. Oral insulin delivery. Adv Drug Deliv Rev 35:249-257.
3. Clement S, Still G, Kosutic G, McAllister RG. 2002. Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: The glucose stabilization effects of HIM2. Diabetes Technol Ther 4:449-466.
4. Cui F, Shi K, Zhang L, Tao A, Kawashima Y. 2006. Biodegradable nano-particles loaded with insulin-phospholipid complex for oral delivery: Preparation, in vitro characterization and in vivo evaluation. J Contr Rel 114:242-250.
5. Cui F, Tao A, Cun D, Zhang L, Shi K. 2007. Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery. J Pharm Sci 96:421-427.
6. Damgé C, Maincent P, Ubrich N. 2007. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J Contr Rel 117:163-170.
7. Damgé C, Michel C, Aprahamian M, Couvreur P. 1988. New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes 37:246-251.
8. Damgé C, Michel C, Aprahamian M, Couvreur P, Devissaguet JP. 1990. Nanocapsules as carriers for oral peptide delivery. J Contr Rel 13:233-239.
9. Desai MP, Labhasetwar V, Amidon GL, Levy RJ. 1996. Gastrointestinal uptake of biodegradable microparticles: Effect of particle size. Pharm Res 13:1838-1845.
10. Eaton RP, Allen RC, Schade DS, Standefer JC. 1980. 'Normal' insulin secretion: The goal of artificial insulin delivery systems?. Diabetes Care 3:270-273.
11. Eneroth G, Ahlund K. 1968. Biological assay of insulin by blood sugar determination in mice. Acta Pharm Suec 5:591-594.
12. Galindo-Rodriguez S, Allemann E, Fessi H, Doelker E. 2004. Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion and nanoprecipitation methods. Pharm Res 21:1428-1439.
13. Jintapattanakit A, Junyaprasert V, Mao S, Sitterberg J, Bakowsky U, Kissel T. 2007. Peroral delivery of insulin using chitosan derivatives: A comparative study of polyelectrolyte nanocomplexes and nanoparticles. Int J Pharm 342:240-249.
14. Kondoh M, Yagi K. 2007. Progress in absorption enhancers based on tight junction. Exp Opin Drug Deliv 4:275-286.
15. Lewis G, Zinman B, Groenewound Y, Vranic M, Giacca A. 1996. Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes 45:454-462.
16. Li Y, Ogris M, Pelisek J, Röedl W. 2004. Stability and release characteristics of poly (d,l-lactide-co-glycolide) encapsulated CaPi-DNA coprecipitation. Int J Pharm 269:61-70.
17. Matsuura J, Powers ME, Manning MC, Shefter E. 1993. Structure and stability of insulin dissolved in 1-octanol. J Am Chem Soc 115:1261-1264.
18. Meyer JD, Manning MC. 1998. Hydrophobic ion pairing: Altering the solubility properties of biomolecules. Pharm Res 15:188-193.
19. Nandi A, Khakhar DV, Mehra A. 2001. Coalescence in surfactant-stabilized emulsions subjected to shear flow. Langmuir 17:2647-2655.
20. Owens DR, Zinman B, Bolli G. 2003. Alternative routes of insulin delivery. Diab Med 20:886-898.
21. Polaschegg E. 1998. Effect of physicochemical variables of regular insulin formulations on their absorption from the subcutaneous tissue. Diabetes Res Clin Pract 40:39-44.
22. Ritschel WA, Ritschel GB, Ritschel BEC, Lucker PW. 1988. Rectal delivery system for insulin. Methods Find Exp Clin Pharmacol 10:645-656.
23. Song X, Zhao Y, Wu W, Bi Y, Cai Z, Chen Q, Li Y, Hou S. 2008. PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: Systematic study of particle size and drug. Int J Pharm 350:320-329.
24. Sun S, Cui F, Kawashima Y, Liang N, Zhang L, Shi K, Yu Y. 2008. A novel insulin-sodium oleate complex for oral administration: Preparation, characterization and in vivo evaluation. J Drug Deliv Sci Tec 18:239-243.